Transtubular Potassium Gradient (TTKG) Calculator

Estimate cortical collecting duct potassium secretory activity to differentiate renal from extra-renal causes of potassium disorders. Applicable to both hyperkalaemia and hypokalaemia, with built-in validity checks for urine osmolality and sodium requirements.

Clinical Tool· Nephrology· Electrolytes

Calculator Understanding TTKG Interpretation Potassium Disorders Special Populations Pitfalls Quick Reference

Calculate TTKG

Enter the serum and urine potassium, serum and urine osmolality, and urine sodium. The calculator will check validity prerequisites (urine osmolality > serum osmolality and urine sodium ≥ 25 mEq/L), then compute the TTKG with context-specific interpretation based on whether the clinical scenario is hyperkalaemia or hypokalaemia.

Serum Values

Serum Potassium (K⁺) mEq/L (mmol/L) · Normal: 3.5–5.0

Serum Osmolality (S_osm) mOsm/kg · Normal: 275–295

Urine Values (Spot Sample)

Urine Potassium (U_K) mEq/L (mmol/L)

Urine Osmolality (U_osm) mOsm/kg · Must be > serum osm for valid TTKG

Urine Sodium (U_Na) mEq/L · Must be ≥ 25 for valid TTKG

Clinical Context Determines interpretation thresholds

Validity Requirements

The TTKG is only valid when two prerequisites are met: (1) Urine osmolality must exceed serum osmolality (U_osm > S_osm), confirming that ADH is active and water reabsorption is occurring in the medullary collecting duct. (2) Urine sodium must be ≥ 25 mEq/L, ensuring adequate distal sodium delivery for potassium secretion. If either condition is not met, the TTKG result is unreliable and should not be used for clinical decision-making.

Understanding the Transtubular Potassium Gradient

The TTKG was developed by Ethier, Kamel, and Halperin in 1990 as a clinical estimate of the potassium concentration gradient in the cortical collecting duct (CCD) — the nephron segment where aldosterone-regulated potassium secretion primarily occurs. It provides an indirect window into aldosterone activity and tubular potassium handling without requiring direct tubular fluid sampling.

The concept relies on two key physiological assumptions. First, in the presence of ADH, water is reabsorbed in the medullary collecting duct, concentrating the urine — by dividing the urine potassium by the urine-to-serum osmolality ratio, the formula “reverses” this water reabsorption to estimate what the potassium concentration was in the CCD before medullary concentration. Second, no significant potassium secretion or reabsorption occurs in the medullary collecting duct itself (a simplification that holds under most clinical conditions).

TTKG Formula

TTKG = (U_K / S_K) / (U_osm / S_osm)

Equivalently:
TTKG = (U_K × S_osm) / (S_K × U_osm)

A higher TTKG indicates a larger potassium gradient across the CCD, reflecting greater aldosterone-mediated potassium secretion.

Worked Example

S_K = 6.2 mEq/L, S_osm = 285 mOsm/kg
U_K = 24 mEq/L, U_osm = 620 mOsm/kg

TTKG = (24 × 285) / (6.2 × 620)
= 6,840 / 3,844 = 1.78

In hyperkalaemia, a TTKG < 7 suggests the kidney is not appropriately secreting potassium — pointing toward hypoaldosteronism or tubular resistance to aldosterone.

Key concept: The TTKG does not measure aldosterone levels directly. It estimates the effect of aldosterone (and other factors) on potassium secretion at the CCD level. A low TTKG in the setting of hyperkalaemia may reflect low aldosterone production, tubular resistance to aldosterone, or insufficient distal sodium delivery — all of which impair potassium excretion but through different mechanisms.

Interpretation by Clinical Context

The TTKG interpretation depends entirely on whether the patient has hyperkalaemia, hypokalaemia, or normal potassium. Different thresholds apply because the expected renal response differs in each scenario. Normal TTKG in eukalemic individuals is approximately 6–12.

Context	TTKG Value	Interpretation	Suggests
Hyperkalaemia (K⁺ > 5.0)	> 7	Appropriate renal K⁺ excretion	Extra-renal cause (shift, cell lysis, intake)
Hyperkalaemia (K⁺ > 5.0)	< 7	Impaired renal K⁺ excretion	Hypoaldosteronism, aldosterone resistance, or tubular defect
Hypokalaemia (K⁺ < 3.5)	> 3	Inappropriate renal K⁺ wasting	Hyperaldosteronism, diuretics, Bartter/Gitelman, RTA
Hypokalaemia (K⁺ < 3.5)	< 2–3	Appropriate renal K⁺ conservation	Extra-renal loss (GI loss, shift, dietary)
Normal K⁺	6–12	Normal aldosterone axis	Baseline reference range

Clinical Pearl

The TTKG can also be used as a dynamic test. In hyperkalaemia with a low TTKG suggesting hypoaldosteronism, administer fludrocortisone (0.05–0.1 mg) and repeat the TTKG after 4–6 hours. A rise in TTKG to > 7 confirms aldosterone deficiency (the tubule responds normally to mineralocorticoid). If the TTKG remains low despite fludrocortisone, the tubule is resistant to aldosterone — seen in voltage-dependent type 4 RTA (e.g. obstructive nephropathy, sickle cell, or drug-induced with trimethoprim, amiloride, or potassium-sparing diuretics).

Differential Diagnosis of Potassium Disorders

The TTKG helps classify the renal contribution to dyskalemia. Combined with clinical history, acid-base status, and medication review, it directs the workup efficiently toward the underlying cause.

Hyperkalaemia with Low TTKG — Renal Causes

A low TTKG (< 7) in the setting of hyperkalaemia indicates that the kidney is failing to excrete potassium appropriately. The differential includes three broad categories based on the level of the defect in the aldosterone axis:

Low aldosterone production: Hyporeninemic hypoaldosteronism (type 4 RTA — most commonly in diabetic nephropathy, mild-to-moderate CKD, and NSAID use), primary adrenal insufficiency (Addison disease), heparin-induced aldosterone suppression, and ACEi/ARB therapy (which reduces angiotensin II-stimulated aldosterone release).
Aldosterone resistance (tubular): Potassium-sparing diuretics (spironolactone, eplerenone, amiloride, triamterene), trimethoprim (blocks ENaC), calcineurin inhibitors (ciclosporin, tacrolimus), and pseudohypoaldosteronism type 1.
Reduced distal sodium delivery: Severe volume depletion, congestive heart failure with renal hypoperfusion, and advanced CKD with very low GFR — in these states, insufficient sodium reaches the CCD for exchange with potassium.

Check serum aldosterone and plasma renin activity/concentration to differentiate: low renin + low aldosterone = hyporeninemic hypoaldosteronism; high renin + low aldosterone = primary adrenal disease; high renin + high aldosterone = tubular resistance.

Hyperkalaemia with High TTKG — Extra-renal Causes

When the TTKG is > 7 in hyperkalaemia, the kidney is responding appropriately by maximally secreting potassium — the problem lies outside the kidney. The main categories of extra-renal hyperkalaemia are:

Transcellular shift (K⁺ moving out of cells): Metabolic acidosis (mineral acid — not organic), insulin deficiency (DKA), beta-blocker overdose, succinylcholine, hyperkalemic periodic paralysis, rhabdomyolysis, tumour lysis syndrome, and massive haemolysis.
Excessive intake: Potassium supplements (oral or IV), massive transfusion (stored blood has high extracellular K⁺), potassium-containing salt substitutes, and high-K⁺ IV fluids.
Pseudohyperkalaemia: Haemolysed specimen (most common), extreme thrombocytosis (> 500 × 10⁹/L), extreme leukocytosis (> 100 × 10⁹/L), prolonged tourniquet time, or mechanical fist clenching during phlebotomy. Always repeat the sample with careful technique before acting on an unexpected potassium elevation.

Hypokalaemia with High TTKG — Renal K⁺ Wasting

A TTKG > 3 in the setting of hypokalaemia indicates that the kidney is inappropriately losing potassium when it should be conserving it. The differential depends on the acid-base status and blood pressure:

With metabolic alkalosis + hypertension: Primary hyperaldosteronism (Conn syndrome), Cushing syndrome, renovascular hypertension, Liddle syndrome, apparent mineralocorticoid excess (liquorice, carbenoxolone).
With metabolic alkalosis + normal/low BP: Diuretic use (loop, thiazide), vomiting (chloride-responsive), Bartter syndrome, Gitelman syndrome.
With metabolic acidosis: Renal tubular acidosis type 1 (distal) and type 2 (proximal), diabetic ketoacidosis (osmotic diuresis), amphotericin B toxicity.
With normal acid-base: Magnesium depletion (impairs ROMK channel closure — always check magnesium in refractory hypokalaemia), early diuretic use, or mild/compensated forms of the above.

Next steps: check blood pressure, arterial/venous blood gas, serum bicarbonate, urine chloride, and serum magnesium. If hyperaldosteronism is suspected, measure aldosterone-to-renin ratio after appropriate washout of interfering drugs.

Hypokalaemia with Low TTKG — Extra-renal K⁺ Loss

A TTKG < 2–3 in hypokalaemia indicates that the kidney is appropriately conserving potassium — the loss is coming from elsewhere. The main extra-renal causes include:

Gastrointestinal losses: Diarrhoea (the most common extra-renal cause worldwide), laxative abuse, villous adenoma, ileostomy/colostomy output, intestinal fistulae. GI fluid below the pylorus is potassium-rich (20–30 mEq/L).
Transcellular shift (K⁺ moving into cells): Insulin administration, beta-2 agonists (salbutamol), refeeding syndrome, thyrotoxic periodic paralysis, familial hypokalaemic periodic paralysis, alkalosis.
Inadequate dietary intake: Rare as a sole cause (the kidney is very efficient at conserving potassium), but may contribute in anorexia nervosa, alcoholism, or severely restricted diets.

Note: in upper GI loss (vomiting), the direct K⁺ loss in gastric fluid is small (~5–10 mEq/L). The resulting hypokalaemia is primarily renal — driven by metabolic alkalosis and volume contraction causing secondary hyperaldosteronism. In this case, the TTKG may actually be elevated despite the primary cause being vomiting, because the kidney becomes the effector of K⁺ loss.

Acid-Base Status & Potassium — Integration

Potassium and acid-base homeostasis are intimately linked. Metabolic acidosis (from mineral acids) drives potassium out of cells, causing hyperkalaemia even when total body potassium may be normal or depleted. Metabolic alkalosis promotes intracellular potassium shift and increases renal K⁺ excretion, causing hypokalaemia. For every 0.1-unit fall in pH, serum potassium rises approximately 0.3–0.6 mEq/L (this relationship is variable and less reliable with organic acidosis like lactic or ketoacidosis).

This means that when interpreting the TTKG, always consider the acid-base context. A patient with DKA and a “normal” potassium of 4.5 mEq/L likely has significant total body potassium depletion that will become apparent as the acidosis is corrected with insulin. Conversely, a patient with chronic vomiting and metabolic alkalosis may have a potassium of 2.8 mEq/L but less total body depletion than the number suggests, because correction of the alkalosis will shift some potassium back out of cells.

Bedside Approach

When evaluating a potassium disorder, follow this sequence: (1) Confirm it is real (repeat sample, rule out pseudohyperkalaemia). (2) Assess urgency — check the ECG for changes (peaked T waves, widened QRS, sine wave in hyperkalaemia; U waves, ST depression in hypokalaemia). (3) Calculate the TTKG to determine if the kidney is contributing. (4) Combine with acid-base status and blood pressure to narrow the differential. (5) Check the medication list — drugs are the single most common cause of both hyperkalaemia and hypokalaemia in hospitalised patients.

Special Populations & Considerations

The TTKG has important limitations and nuances in specific clinical settings. Understanding these ensures appropriate application and avoids misinterpretation.

CKD

Chronic Kidney Disease

In advanced CKD (eGFR < 15 mL/min), the TTKG may be unreliable because very few functioning nephrons remain, limiting distal K⁺ secretion irrespective of aldosterone activity. Additionally, colonic potassium excretion (which can account for up to 30–40% of total K⁺ excretion in ESRD) is not captured by the TTKG. In dialysis patients, the TTKG has limited clinical utility — serum potassium management relies on dialysis prescription, diet, and medication adjustment.

💊

Drug-Induced Dyskalemia

Numerous drugs alter potassium handling at the tubular level and directly affect the TTKG. ACE inhibitors, ARBs, and direct renin inhibitors reduce aldosterone, lowering the TTKG. Spironolactone and eplerenone block the mineralocorticoid receptor. Trimethoprim and amiloride block ENaC. Calcineurin inhibitors impair K⁺ secretion through multiple mechanisms. Conversely, loop and thiazide diuretics increase distal Na⁺ delivery and flow, raising the TTKG and promoting K⁺ wasting.

🧂

Volume-Depleted Patients

Severe volume depletion may render the TTKG invalid or misleading. Avid proximal sodium reabsorption reduces distal Na⁺ delivery below the threshold needed for K⁺ exchange, causing low urine Na⁺ (< 25 mEq/L) and invalidating the TTKG. Additionally, volume depletion concentrates the urine independently of ADH, complicating the osmolality correction. In these patients, the TTKG should not be calculated — instead, assess potassium handling after appropriate volume resuscitation.

🧪

Urea & Osmolality Caveats

The TTKG formula assumes that urea equilibrates freely across the medullary collecting duct. In states of high urea (e.g. high-protein diets, GI bleeding, catabolic states), urea contributes significantly to urine osmolality but does not create a true osmotic gradient for water reabsorption. This can make the U_osm > S_osm prerequisite appear met when functionally it is not, leading to an underestimate of the true TTKG. Some authors suggest using urea-free osmolality for a more accurate calculation.

Contemporary debate: In 2011, Kamel and Halperin (original authors of the TTKG) published a reassessment noting that urea recycling in the medullary collecting duct may affect the accuracy of the TTKG more than originally appreciated, particularly when urine osmolality is very high. While they did not formally retract the TTKG, they urged caution and suggested using it primarily as a qualitative tool (clearly high vs clearly low) rather than relying on precise numerical thresholds. The TTKG remains widely taught and clinically used but should be interpreted as an estimate, not a definitive measure.

Common Pitfalls & Limitations

Calculating the TTKG when validity prerequisites are not met

The TTKG is only meaningful when two conditions are satisfied: urine osmolality exceeds serum osmolality (ensuring ADH-mediated water reabsorption is occurring), and urine sodium is at least 25 mEq/L (ensuring adequate distal sodium delivery for K⁺ exchange). If either criterion is not met, the calculated TTKG number is physiologically meaningless and should not influence clinical decisions. The most common scenario where this matters is in volume-depleted patients with low urine sodium — the kidney is reabsorbing sodium avidly, leaving insufficient substrate for K⁺ secretion regardless of aldosterone status.

Using hypokalaemia thresholds in a hyperkalaemic patient (and vice versa)

The TTKG thresholds are context-dependent and cannot be applied interchangeably. In hyperkalaemia, a TTKG > 7 represents appropriate renal response; in hypokalaemia, a TTKG > 3 represents inappropriate renal wasting. Using the wrong threshold leads to incorrect classification of the renal contribution. Always select the correct clinical context before interpreting the numerical result. A TTKG of 5, for example, means “kidney is not adequately excreting K⁺” in hyperkalaemia but “kidney is wasting K⁺” in hypokalaemia — the same number carries opposite clinical implications depending on the context.

Treating the TTKG as a precise quantitative measure

The TTKG was originally presented as a reasonably accurate estimate of the CCD potassium gradient, but subsequent work (including by the original authors, Kamel and Halperin, 2011) has highlighted that the medullary collecting duct does participate in potassium handling more than initially assumed, and that urea recycling affects the osmolality correction. The TTKG is therefore best used as a qualitative discriminator — a clearly low value (< 3 in hyperkalaemia) or a clearly high value (> 8 in hypokalaemia) is informative, but values near the threshold should be interpreted cautiously and in conjunction with other clinical data (serum aldosterone, renin, urine electrolytes, acid-base status).

Forgetting to check magnesium in refractory hypokalaemia

While not a TTKG-specific pitfall, this is the most commonly missed step in hypokalaemia workup. Magnesium depletion impairs the ability of ROMK channels in the CCD to close, leading to ongoing renal potassium wasting that is refractory to potassium replacement. The TTKG will be elevated (suggesting renal K⁺ loss), but the underlying cause is magnesium deficiency, not primary hyperaldosteronism. Potassium will not correct until magnesium is repleted. Always check serum magnesium — and bear in mind that serum levels can be normal even with significant intracellular depletion.

Ignoring the medication list as the most common cause

In hospitalised patients, medications are the single most common cause of both hyperkalaemia and hypokalaemia. Before embarking on an elaborate TTKG-guided workup, always review the drug chart systematically. Common potassium-raising drugs include ACEi/ARBs, spironolactone/eplerenone, NSAIDs, trimethoprim, heparin, calcineurin inhibitors, beta-blockers, and potassium supplements. Common potassium-lowering drugs include loop diuretics, thiazides, insulin, beta-2 agonists, corticosteroids, amphotericin B, and laxatives. A thorough medication review often reveals the cause before any urinary electrolytes are ordered.

Quick Reference Summary

> 7 TTKG threshold for appropriate K⁺ excretion in hyperkalaemia

< 3 TTKG suggesting appropriate K⁺ conservation in hypokalaemia

≥ 25 Minimum urine Na⁺ (mEq/L) required for valid TTKG

6–12 Normal TTKG range in eukalemic individuals

Scenario	TTKG	Interpretation	Key Next Steps
Hyperkalaemia + Low TTKG	< 7	Renal cause — impaired K⁺ secretion	Aldosterone/renin levels; stop offending drugs; fludrocortisone trial
Hyperkalaemia + High TTKG	> 7	Extra-renal cause — kidneys responding appropriately	Rule out pseudohyperkalaemia, cell lysis, shift, intake
Hypokalaemia + High TTKG	> 3	Renal K⁺ wasting	BP, acid-base, Mg²⁺, aldosterone/renin, urine Cl⁻
Hypokalaemia + Low TTKG	< 2–3	Extra-renal K⁺ loss	GI history (diarrhoea, vomiting, laxatives); shift causes
TTKG invalid	—	Validity criteria not met	Resuscitate volume; recheck after U_Na ≥ 25, U_osm > S_osm

The Golden Rule: Always check the validity prerequisites before interpreting the TTKG. A number without valid conditions is just a number — not a diagnosis. And remember: use the TTKG as a qualitative guide (clearly high vs clearly low), not a precise quantitative instrument.

Disclaimer & References

Disclaimer

For Educational Purposes Only. This calculator and the accompanying clinical information are intended as educational tools for healthcare professionals. They do not replace clinical judgement. Results should be interpreted in the full clinical context. Lab reference ranges vary by institution — verify with your own laboratory. Drug dosages should be confirmed against current prescribing information.

References

Ethier JH, Kamel KS, Magner PO, Lemann J Jr, Halperin ML. The transtubular potassium concentration in patients with hypokalemia and hyperkalemia. Am J Kidney Dis. 1990;15(4):309–315. DOI: 10.1016/S0272-6386(12)80076-X
Kamel KS, Halperin ML. Intrarenal urea recycling leads to a higher rate of renal excretion of potassium: an hypothesis with clinical implications. Curr Opin Nephrol Hypertens. 2011;20(5):547–554. DOI: 10.1097/MNH.0b013e328349b4ec
Palmer BF. A physiologic-based approach to the evaluation of a patient with hypokalemia. Am J Kidney Dis. 2010;56(6):1184–1190. DOI: 10.1053/j.ajkd.2010.07.011
Palmer BF. Regulation of potassium homeostasis. Clin J Am Soc Nephrol. 2015;10(6):1050–1060. DOI: 10.2215/CJN.08580813
Mount DB. Disorders of potassium balance. In: Yu ASL, et al., eds. Brenner and Rector’s The Kidney. 11th ed. Elsevier; 2020:559–600.
Choi MJ, Ziyadeh FN. The utility of the transtubular potassium gradient in the evaluation of hyperkalemia. J Am Soc Nephrol. 2008;19(3):424–426. DOI: 10.1681/ASN.2007091017
Palmer BF, Clegg DJ. Physiology and pathophysiology of potassium homeostasis: core curriculum 2019. Am J Kidney Dis. 2019;74(5):682–695. DOI: 10.1053/j.ajkd.2019.03.427
West ML, Marsden PA, Richardson RM, Zettle RM, Halperin ML. New clinical approach to evaluate disorders of potassium excretion. Miner Electrolyte Metab. 1986;12(4):234–238. PMID: 3762510